UniProt ID | FBX9_HUMAN | |
---|---|---|
UniProt AC | Q9UK97 | |
Protein Name | F-box only protein 9 | |
Gene Name | FBXO9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 447 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of TTI1 and TELO2 in a CK2-dependent manner, thereby directly regulating mTOR signaling. SCF(FBXO9) recognizes and binds mTORC1-bound TTI1 and TELO2 when they are phosphorylated by CK2 following growth factor deprivation, leading to their degradation. In contrast, the SCF(FBXO9) does not mediate ubiquitination of TTI1 and TELO2 when they are part of the mTORC2 complex. As a consequence, mTORC1 is inactivated to restrain cell growth and protein translation, while mTORC2 is activated due to the relief of feedback inhibition by mTORC1.. | |
Protein Sequence | MPDIIWVFPPQAEAEEDCHSDTVRADDDEENESPAETDLQAQLQMFRAQWMFELAPGVSSSNLENRPCRAARGSLQKTSADTKGKQEQAKEEKARELFLKAVEEEQNGALYEAIKFYRRAMQLVPDIEFKITYTRSPDGDGVGNSYIEDNDDDSKMADLLSYFQQQLTFQESVLKLCQPELESSQIHISVLPMEVLMYIFRWVVSSDLDLRSLEQLSLVCRGFYICARDPEIWRLACLKVWGRSCIKLVPYTSWREMFLERPRVRFDGVYISKTTYIRQGEQSLDGFYRAWHQVEYYRYIRFFPDGHVMMLTTPEEPQSIVPRLRTRNTRTDAILLGHYRLSQDTDNQTKVFAVITKKKEEKPLDYKYRYFRRVPVQEADQSFHVGLQLCSSGHQRFNKLIWIHHSCHITYKSTGETAVSAFEIDKMYTPLFFARVRSYTAFSERPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 (in isoform 2) | Phosphorylation | - | 34.25 | 24719451 | |
20 | Phosphorylation | EAEEDCHSDTVRADD HHCCCCCCCCCCCCC | 41.11 | 23663014 | |
33 | Ubiquitination | DDDEENESPAETDLQ CCCCCCCCCHHHHHH | 40.78 | 29967540 | |
33 | Phosphorylation | DDDEENESPAETDLQ CCCCCCCCCHHHHHH | 40.78 | 27732954 | |
37 | Phosphorylation | ENESPAETDLQAQLQ CCCCCHHHHHHHHHH | 44.08 | 26471730 | |
41 | Ubiquitination | PAETDLQAQLQMFRA CHHHHHHHHHHHHHH | 21.24 | 24816145 | |
67 | Ubiquitination | SSNLENRPCRAARGS CCCCCCCCCHHHHHC | 24.43 | 29967540 | |
71 (in isoform 3) | Ubiquitination | - | 9.30 | 21890473 | |
71 | Ubiquitination | ENRPCRAARGSLQKT CCCCCHHHHHCCCCC | 9.30 | 21890473 | |
74 | Phosphorylation | PCRAARGSLQKTSAD CCHHHHHCCCCCCCC | 23.29 | 28102081 | |
75 | Ubiquitination | CRAARGSLQKTSADT CHHHHHCCCCCCCCC | 7.24 | 24816145 | |
77 | Ubiquitination | AARGSLQKTSADTKG HHHHCCCCCCCCCCC | 50.14 | 29967540 | |
85 | Ubiquitination | TSADTKGKQEQAKEE CCCCCCCHHHHHHHH | 52.82 | 24816145 | |
105 (in isoform 2) | Ubiquitination | - | 35.52 | 21890473 | |
105 | Ubiquitination | FLKAVEEEQNGALYE HHHHHHHHHCCHHHH | 35.52 | 21890473 | |
111 | Phosphorylation | EEQNGALYEAIKFYR HHHCCHHHHHHHHHH | 11.63 | 21945579 | |
115 (in isoform 1) | Ubiquitination | - | 43.31 | 21890473 | |
115 | Ubiquitination | GALYEAIKFYRRAMQ CHHHHHHHHHHHHHH | 43.31 | 21890473 | |
115 | Acetylation | GALYEAIKFYRRAMQ CHHHHHHHHHHHHHH | 43.31 | 18603043 | |
115 | Ubiquitination | GALYEAIKFYRRAMQ CHHHHHHHHHHHHHH | 43.31 | 22817900 | |
121 | Sulfoxidation | IKFYRRAMQLVPDIE HHHHHHHHHHCCCEE | 2.76 | 21406390 | |
130 | Acetylation | LVPDIEFKITYTRSP HCCCEEEEEEEEECC | 22.73 | 18603053 | |
132 | Phosphorylation | PDIEFKITYTRSPDG CCEEEEEEEEECCCC | 21.30 | 28450419 | |
133 | Phosphorylation | DIEFKITYTRSPDGD CEEEEEEEEECCCCC | 12.02 | 28450419 | |
134 | Phosphorylation | IEFKITYTRSPDGDG EEEEEEEEECCCCCC | 18.93 | 28450419 | |
136 | Phosphorylation | FKITYTRSPDGDGVG EEEEEEECCCCCCCC | 21.39 | 25159151 | |
145 | Phosphorylation | DGDGVGNSYIEDNDD CCCCCCCCCCCCCCC | 22.89 | 23186163 | |
195 (in isoform 2) | Phosphorylation | - | 2.79 | 24719451 | |
205 | Phosphorylation | YIFRWVVSSDLDLRS HHHHHHHCCCCCCCC | 14.44 | 24719451 | |
207 (in isoform 2) | Phosphorylation | - | 36.37 | 24719451 | |
217 | Phosphorylation | LRSLEQLSLVCRGFY CCCHHHHHHHHHEEE | 20.60 | 24719451 | |
266 (in isoform 2) | Phosphorylation | - | 9.79 | 24719451 | |
276 | Phosphorylation | VYISKTTYIRQGEQS EEEECCEEEEECCCC | 10.19 | 24719451 | |
296 | Phosphorylation | RAWHQVEYYRYIRFF HHHHHHEEEEEEEEC | 8.39 | - | |
297 | Phosphorylation | AWHQVEYYRYIRFFP HHHHHEEEEEEEECC | 5.39 | - | |
345 | Phosphorylation | HYRLSQDTDNQTKVF EEEECCCCCCCEEEE | 29.25 | 22210691 | |
349 | Phosphorylation | SQDTDNQTKVFAVIT CCCCCCCEEEEEEEE | 35.12 | 22210691 | |
429 | Phosphorylation | FEIDKMYTPLFFARV EEECCCCCCCHHHHH | 15.26 | 30631047 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBX9_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBX9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBX9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SKP1_HUMAN | SKP1 | physical | 17463251 | |
EF2_HUMAN | EEF2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...